+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Raloxifene"

From
Raloxifene Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Raloxifene Hydrochloride - Global Strategic Business Report

  • Report
  • March 2025
  • 177 Pages
  • Global
From
Raloxifene Hydrochloride Market 2025-2029 - Product Thumbnail Image

Raloxifene Hydrochloride Market 2025-2029

  • Report
  • February 2025
  • 215 Pages
  • Global
From
From
Osteoporosis Drugs Market Report 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Raloxifene is a selective estrogen receptor modulator (SERM) used to treat and prevent breast cancer in postmenopausal women. It is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are at high risk for invasive breast cancer. Raloxifene works by blocking the effects of estrogen in breast tissue, which can help reduce the risk of breast cancer. It also helps to reduce the risk of fractures in postmenopausal women with osteoporosis. Raloxifene is available in both oral and injectable forms. It is usually taken once a day, either with or without food. Common side effects of raloxifene include hot flashes, leg cramps, and joint pain. Raloxifene is a widely used breast cancer drug, and is available from many pharmaceutical companies. Some of the companies that produce raloxifene include Pfizer, Novartis, and Mylan. Show Less Read more